Pamela S. Larson, PhD

Instructor, Pathology & Laboratory Medicine

(617) 414-1839
670 Albany St Biosquare III

Biography

Expertise in breast cancer genetics.

Other Positions

  • Boston Medical Center

Education

  • Massachusetts Institute of Technology, PhD
  • University of New Hampshire, MS
  • University of New Hampshire, BA

Publications

  • Published on 3/6/2008

    Larson PS, Schlechter BL, King CL, Yang Q, Glass CN, Mack C, Pistey R, de Las Morenas A, Rosenberg CL. CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer. 2008; 8:68. PMID: 18325103.

    Read at: PubMed
  • Published on 11/1/2006

    Larson PS, Ungarelli RA, de Las Morenas A, Cupples LA, Rowlings K, Palmer JR, Rosenberg CL. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. Cancer. 2006 Nov 1; 107(9):2122-6. PMID: 16998936.

    Read at: PubMed
  • Published on 7/1/2006

    Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol. 2006 Jul; 209(3):307-16. PMID: 16604511.

    Read at: PubMed
  • Published on 12/1/2005

    Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol. 2005 Dec 1; 23(34):8613-9. PMID: 16314623.

    Read at: PubMed
  • Published on 5/15/2004

    Schlechter BL, Yang Q, Larson PS, Golubeva A, Blanchard RA, de las Morenas A, Rosenberg CL. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol. 2004 May 15; 22(10):1830-8. PMID: 15143075.

    Read at: PubMed
  • Published on 10/10/2003

    Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, Blanchard RA, Rosenberg CL. Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer. Int J Cancer. 2003 Oct 10; 106(6):923-9. PMID: 12918071.

    Read at: PubMed
  • Published on 7/1/2002

    Larson PS, de las Morenas A, Bennett SR, Cupples LA, Rosenberg CL. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol. 2002 Jul; 161(1):283-90. PMID: 12107113.

    Read at: PubMed
  • Published on 3/20/2000

    Rosenberg CL, Finnemore EM, Larson PS, Nogueira CP, Delaney TL. DNA alterations in tumor scrapes vs. biopsies of squamous-cell carcinomas of the head and neck. Int J Cancer. 2000 Mar 20; 89(2):105-10. PMID: 10754486.

    Read at: PubMed
  • Published on 10/1/1999

    Zucca MP, Larson PS, Rosenberg CL, de las Morenas A. Lack of correlation between morphometric analysis and presence of microsatellite alterations in proliferative ductal lesions of the breast. Anal Quant Cytol Histol. 1999 Oct; 21(5):369-73. PMID: 10560518.

    Read at: PubMed
  • Published on 11/1/1998

    Lazar AD, Winter MR, Nogueira CP, Larson PS, Finnemore EM, Dolan RW, Fuleihan N, Chakravarti A, Zietman A, Rosenberg CL. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res. 1998 Nov; 4(11):2787-93. PMID: 9829743.

    Read at: PubMed

View 3 more publications: View full profile at BUMC

View all profiles